Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Aug;40(8 Pt 1-2):1486–1494. doi: 10.1172/JCI104379

URIC ACID METABOLISM IN PSORIASIS

Arthur Z Eisen 1,*, J E Seegmiller 1
PMCID: PMC292529  PMID: 13726168

Full text

PDF
1489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARCHIBALD R. M. Colorimetric measurement of uric acid. Clin Chem. 1957 Apr;3(2):102–105. [PubMed] [Google Scholar]
  2. BENEDICT J. D., FORSHAM P. H., ROCHE M., SOLOWAY S., STETTEN D., Jr The effect of salicylates and adrenocorticotropic hormone upon the miscible pool of uric acid in gout. J Clin Invest. 1950 Aug;29(8):1104–1111. doi: 10.1172/JCI102343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BENEDICT J. D., FORSHAM P. H., STETTEN D., Jr The metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid. J Biol Chem. 1949 Nov;181(1):183–193. [PubMed] [Google Scholar]
  4. BENEDICT J. D., ROCHE M., YU T. F., BIEN E. J., GUTMAN A. B., STETTEN D., Jr Incorporation of glycine nitrogen into uric acid in normal and gouty man. Metabolism. 1952 Jan;1(1):3–12. [PubMed] [Google Scholar]
  5. BENEDICT J. D., YU T. F., BIEN E. J., GUTMAN A. B., STETTEN D., Jr A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J Clin Invest. 1953 Aug;32(8):775–777. doi: 10.1172/JCI102791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BIEN E. J., ZUCKER M. Uricolysis in normal and gouty individuals. Ann Rheum Dis. 1955 Dec;14(4):409–411. doi: 10.1136/ard.14.4.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BISHOP C., GARNER W., TALBOTT J. H. Pool size, turnover rate, and rapidity of equilibration of injected isotopic uric acid in normal and pathological subjects. J Clin Invest. 1951 Aug;30(8):879–888. doi: 10.1172/JCI102504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. BISHOP C., RAND R., TALBOTT J. H. The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject. J Clin Invest. 1951 Aug;30(8):889–895. doi: 10.1172/JCI102505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CRADDOCK C. G., Jr, PERRY S., LAWRENCE J. S. The dynamics of leukopenia and leukocytosis. Ann Intern Med. 1960 Feb;52:281–294. doi: 10.7326/0003-4819-52-2-281. [DOI] [PubMed] [Google Scholar]
  10. EVANS E. I., PURNELL O. J., ROBINETT P. W., BATCHELOR A., MARTIN M. Fluid and electrolyte requirements in severe burns. Ann Surg. 1952 Jun;135(6):804–817. doi: 10.1097/00000658-195206000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GUTMAN A. B., KUPFER S., SHARNEY L., WEISSMANN B., YU T. F. On the biosynthesis of uric acid from glycine-N15 in primary and secondary polycythemia. Am J Med. 1956 Dec;21(6):901–917. doi: 10.1016/0002-9343(56)90106-1. [DOI] [PubMed] [Google Scholar]
  12. GUTMAN A. B., YU T. F., BLACK H., YALOW R. S., BERSON S. A. Incorporation of glycine-1-C14, glycine-2-C14 and glycine-N15 into uric acid in normal and gouty subjects. Am J Med. 1958 Dec;25(6):917–932. doi: 10.1016/0002-9343(58)90063-9. [DOI] [PubMed] [Google Scholar]
  13. KAPLAN H., KLATSKIN G. Sarcoidosis, psoriasis, and gout: syndrome or coincidence? Yale J Biol Med. 1960 Apr;32:335–352. [PMC free article] [PubMed] [Google Scholar]
  14. KUZELL W. C., SCHAFFARZICK R. W., NAUGLER W. E., KOETS P., MANKLE E. A., BROWN B., CHAMPLIN B. Some observations on 520 gouty patients. J Chronic Dis. 1955 Dec;2(6):645–669. doi: 10.1016/0021-9681(55)90193-4. [DOI] [PubMed] [Google Scholar]
  15. LASTER L., MULLER A. F. Uric acid production in a case of myeloid metaplasia associated with gouty arthritis, studied with N15 labeled glycine. Am J Med. 1953 Dec;15(6):857–861. doi: 10.1016/0002-9343(53)90176-4. [DOI] [PubMed] [Google Scholar]
  16. LIDDLE L., SEEGMILLER J. E., LASTER L. The enzymatic spectrophotometric method for determination of uric acid. J Lab Clin Med. 1959 Dec;54:903–913. [PubMed] [Google Scholar]
  17. PRAETORIUS E., POULSEN H. Enzymatic determination of uric acid; with detailed directions. Scand J Clin Lab Invest. 1953;5(3):273–280. doi: 10.3109/00365515309094197. [DOI] [PubMed] [Google Scholar]
  18. SEEGMILLER J. E., GRAYZEL A. I., LASTER L., LIDDLE L. Uric acid production in gout. J Clin Invest. 1961 Jul;40:1304–1314. doi: 10.1172/JCI104360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SEEGMILLER J. E., LASTER L., LIDDLE L. V. Failure to detect consistent overincorporation of glycine-1-C14 into uric acid in primary gout. Metabolism. 1958 Jul;7(4 Pt 1):376–377. [PubMed] [Google Scholar]
  20. SORENSEN L. B. Degradation of uric acid in man. Metabolism. 1959 Sep;8:687–703. [PubMed] [Google Scholar]
  21. STEINBERG A. G., BECKER S. W., Jr, FITZPATRICK T. B., KIERLAND R. R. A genetic and statistical study of psoriasis. Am J Hum Genet. 1951 Sep;3(3):267–281. [PMC free article] [PubMed] [Google Scholar]
  22. VAN SCOTT E. J., REINERTSON R. P. Morphologic and physiologic effects of chemotherapeutic agents in psoriasis. J Invest Dermatol. 1959 Dec;33:357–369. doi: 10.1038/jid.1959.161. [DOI] [PubMed] [Google Scholar]
  23. WYNGAARDEN J. B., BLAIR A. E., HILLEY L. On the mechanism of overproduction of uric acid in patients with primary gout. J Clin Invest. 1958 Apr;37(4):579–590. doi: 10.1172/JCI103641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. WYNGAARDEN J. B. Normal glycine-C14-incorporation into uric acid in primary gout. Metabolism. 1958 Jul;7(4 Pt 1):374–375. [PubMed] [Google Scholar]
  25. WYNGAARDEN J. B. Overproduction of uric acid as the cause of hyperuricemia in primary gout. J Clin Invest. 1957 Oct;36(10):1508–1515. doi: 10.1172/JCI103547. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES